levonorgestrel has been researched along with Atypical Endometrial Hyperplasia in 135 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.74) | 18.7374 |
| 1990's | 4 (2.96) | 18.2507 |
| 2000's | 29 (21.48) | 29.6817 |
| 2010's | 67 (49.63) | 24.3611 |
| 2020's | 34 (25.19) | 2.80 |
| Authors | Studies |
|---|---|
| Campo, G; Candiani, M; Giardina, P; Pagliardini, L; Papaleo, E; Patruno, C; Rebecchi, A; Vanni, VS | 1 |
| George, M; Kalantaridou, S; Papadimitriou, S; Paschopoulos, M; Tsonis, O; Zisi, M; Zygouris, D | 1 |
| Arencibia Sánchez, O; Bataller, Á; Cabrera, S; Corbalán, S; Coronado, P; Domingo, J; Domingo, S; Espinosa, E; Fiol, G; Gil-Ibañez, B; Gil-Moreno, A; Iacoponi, S; Lago, V; Laseca Modrego, M; Marina, T; Martín Salamanca, B; Minig, L; Munmanny, M; Padilla-Iserte, P; Rodriguez, JR; Sala Ferichola, M; Utrilla-Layna, J | 1 |
| Contreras, NA; Fernández-Montolí, ME; Julià, C; Sabadell, J; Verdaguer, P | 1 |
| Buca, D; D'Antonio, F; De Rocco, S; Dessole, M; Fanfani, F; Leombroni, M; Liberati, M; Lucidi, A; Nappi, L; Oronzii, L; Petrillo, M; Scambia, G | 1 |
| Jiang, J; Li, X; Peng, H | 1 |
| Abdallah, NA; AlMahdy, AM; El-Zohiry, MM; Elassall, GM; Elazeem, HASA; Radwan, AA; Sayed, EG; Sedik, AS; Shazly, SA | 1 |
| Hirata, T; Ikeda, T; Kondo, E; Kubo-Kaneda, M; Maezawa, T; Magawa, S; Nii, M; Tabata, T; Yoshida, K | 1 |
| Catania, F; Centini, G; Exacoustos, C; Giorgi, M; Labanca, L; Lazzeri, L; Martire, FG; Zupi, E | 1 |
| Liu, Z; Niu, J; Shi, C; Zhao, X | 1 |
| Cao, D; Chen, J; Cheng, N; Peng, P; Shen, K; Wang, J; Yang, J; Yu, M; Zhang, Y; Zhou, H | 1 |
| Deng, C; Gu, Y; Jin, Y; Li, Y; Pan, L; Wang, H; Wang, W; Yin, J | 1 |
| Aksoy, L; Gezer, Ş; Köle, E | 1 |
| Chin, JPS; Mok, ZW | 1 |
| Arencibia Sánchez, O; Emergi Zhrigen, Y; Gil González, Y; Laseca Modrego, M; Martín Martínez, AI; Nieto Naya, MÁ; Ocón Padrón, L; Pérez Matos, C; Pérez Morales, ME; Sánchez Sánchez, V; Santana Suárez, MA | 1 |
| Chen, L; de Meritens, AB; Hershman, DL; Hou, JY; Khoury-Collado, F; Matsuo, K; Melamed, A; St Clair, CM; Suzuki, Y; Wright, JD | 1 |
| Chen, X; Guan, J; Liao, J; Luo, X; Ma, F; Ning, C; Shan, W; Shao, W; Wu, P; Xu, Z; Yang, B; Zhang, H; Zhou, S; Zhu, Q | 1 |
| Auclair, MH; Colgan, TTJ; Salvador, S; Sebastianelli, A; Thurston, J; Yong, PJ | 1 |
| Ciccone, MA; Dancz, CE; Khoshchehreh, M; Mandelbaum, RS; Matsuo, K; Matsuzaki, S; Morocco, EB; Nusbaum, DJ; Ozel, B; Paulson, RJ; Purswani, H; Roman, LD; Smith, MB | 1 |
| Hong, JH; Kang, SB; Kim, MK; Park, DC; Roh, JW; Seong, SJ | 1 |
| Koskas, M; Maumy, L; Peigné, M | 1 |
| Sager, G; Sletten, ET; Smaglyukova, N; Ørbo, A | 1 |
| Gowri, V; Rawahi, TA; Shikeli, S | 1 |
| Bodurka, DC; Broaddus, RR; Burzawa, JK; Coleman, RL; Fellman, B; Fleming, ND; Lu, KH; Milbourne, AM; Nick, AM; Pal, N; Ramondetta, LM; Schmeler, KM; Soliman, PT; Sun, CC; Urbauer, DL; Westin, SN; Woodall, ML; Yates, MS; Yuan, Y | 1 |
| Du, H; Jiang, J; Peng, H | 1 |
| Farrant, C; Mittermeier, T; Wise, MR | 1 |
| He, Y; Wang, J; Wang, Y; Zhou, R | 1 |
| Bifulco, G; De Franciscis, P; Di Spiezio Sardo, A; Gencarelli, A; Insabato, L; Micheli, M; Miranda, S; Raffone, A; Travaglino, A; Zullo, F; Zullo, FM | 1 |
| Bosco, M; Franchi, MP; Garzon, S; Mariani, A; Student, V; Uccella, S; Zorzato, PC | 1 |
| Cho, A; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, SW; Park, JY; Suh, DS | 1 |
| Hickey, M; Romero, SA; Su, HI; Young, K | 1 |
| Andreeva, YY; Krasnopolskaya, KV; Nosov, VB; Novikova, EG; Novikova, OV; Panov, VA; Shevchuk, AS | 1 |
| Bagga, R; Jain, V; Kalra, J; Ravi, RD; Sachdeva, N; Srinivasan, R; Suri, V | 1 |
| Contreras-Perez, NA; Fernandez-Montoli, ME; Sabadell, J | 1 |
| Arnold, JJ; Silver, S | 1 |
| Baker, WD; Duska, LR; Gehrig, PA; Mills, AM; Pierce, SR | 1 |
| Arnes, M; Lysa, LM; Moe, BT; Orbo, A; Sletten, ET; Straume, B | 1 |
| Cao, D; Lang, J; Shen, K; Yang, J; Zhou, H | 1 |
| Goldstein, SR; Lumsden, MA | 1 |
| Balakrishnan, N; Bodurka, DC; Broaddus, RR; Lu, KH; Meyer, LA; Milbourne, A; Pal, N; Ramirez, PT; Ramondetta, L; Schmeler, KM; Soliman, PT; Urbauer, DL; Westin, SN | 1 |
| Davey, DA | 1 |
| Arnes, M; Sletten, ET; Vereide, AB; Ørbo, A | 1 |
| Li, J; Luo, B; Luo, L; Sidell, N; Zhang, H; Zheng, Y | 2 |
| Chen, X | 1 |
| Bogani, G; Chiappa, V; Ditto, A; Dondi, G; Evangelista, MT; Ferrero, S; Leone Roberti Maggiore, U; Liberale, V; Martinelli, F; Raspagliesi, F | 1 |
| Gallos, ID; Ganesan, R; Gupta, JK; Krishan, P; Shehmar, M | 2 |
| Devey, J; Gallos, ID; Ganesan, R; Gupta, JK | 1 |
| Chan, SSC; Tam, WH; Wong, AWY; Yeo, W; Yu, MY | 1 |
| Giacobbe, V; Palmara, V; Retto, A; Santoro, G; Sturlese, E; Villari, D | 1 |
| Baloglu, A; Boz, A; Dolapcioglu, K | 1 |
| Schorge, JO | 1 |
| Gallos, ID; Ganesan, R; Gupta, JK | 1 |
| Caputo, TA; Gupta, D; Holcomb, KM; Kligman, I; Kudesia, R; Rosenwaks, Z; Singer, T | 1 |
| Chiti, Z; Dehghani, A; Dehghani-Firoozabadi, R; Dehghani-Firoozabadi, Z; Karimi-Zarchi, M; Miratashi-Yazdi, A; Tabatabaie, A; Teimoori, S | 1 |
| Arnes, M; Orbo, A; Pettersen, I; Straume, B; Vereide, A | 1 |
| Munro, MG; Solnik, MJ | 1 |
| Arnes, M; Hvingel, B; Orbo, A | 1 |
| Hu, Y; Lin, M; Wang, Y; Xu, X; Zhao, Y | 1 |
| El Behery, MM; Ibrahiem, MA; Kamal, EM; Kassem, GA; Mohamed, Mel S; Saleh, HS | 1 |
| Andreeva, IuIu; Danilova, NV; Lozovaia, IuA; Novikova, EG; Novikova, OV; Podtetenev, DV; Pronin, SM; Rubtsova, NA; Vostrov, AN | 1 |
| Li, J; Li, M; Shi, Q; Wu, J; Xing, A; Yao, Q | 1 |
| Bian, J; Fang, L; Li, H; Liu, H; Shao, H; Tao, M; Wang, L; Xing, C | 1 |
| Depypere, H; Inki, P | 1 |
| Abu Hashim, H; El Rakhawy, M; Ghayaty, E | 1 |
| Bae, DS; Jeon, S; Kim, JW; Kim, MK; Kwon, SH; Lee, TS; Seong, SJ | 1 |
| Jóźwik, M; Modzelewska, B; Niewińska, M | 1 |
| Joo, WD; Ki, KD; Kim, K; Kim, MK; Kim, YH; Lee, TS; Lim, MC; Seong, SJ | 1 |
| Leake, R; Stewart, CJ | 1 |
| Arnes, M; Straume, B; Vereide, AB; Ørbo, A | 1 |
| Arnes, M; Lyså, LM; Straume, B; Ørbo, A | 1 |
| Chin, J; Dominick, S; Hickey, M; Su, HI | 1 |
| Cholakian, D; Fader, AN; Gehrig, PA; Hacker, K; Tanner, EJ | 1 |
| Choi, HS; Jeon, S; Ju, W; Kang, SB; Kim, JW; Kim, MK; Lee, C; Lee, IH; Lee, JH; Park, H; Ryu, HS; Seong, SJ; Song, ES | 1 |
| Gallos, ID | 1 |
| Liegl, S | 1 |
| Arnes, M; Borgfeldt, C; Lyså, LM; Straume, B; Ørbo, A | 1 |
| Ahn, HS; Kim, HJ; Lee, JH; Park, WI; Song, JY; Yuk, JS | 1 |
| Hanna, LS; van der Meer, AC | 1 |
| Bahamondes, L; Bahamondes, MV; Monteiro, I | 1 |
| Arnes, M; Hancke, C; Larsen, K; Pettersen, I; Vereide, AB; Ørbo, A | 1 |
| Candiotto, A; Guaschino, S; Inglese, S; Ronfani, L; Scrimin, F; Wiesenfeld, U | 1 |
| Loisel, C; Marpeau, L; Puscasiu, L; Roman, H; Sentilhes, L | 1 |
| Buttini, MJ; Jordan, SJ; Webb, PM | 1 |
| Chin, J; Hickey, M; Konje, JC | 1 |
| Alanbay, I; Baser, I; Duru, NK; Ercan, CM; Karasahin, KE; Sakinci, M | 1 |
| Akesson, E; Gallos, ID; Ganesan, R; Gupta, JK; Varma, R | 1 |
| Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
| Curtis, KM; Marchbanks, PA; Tepper, NK; Whiteman, MK; Zapata, LB | 1 |
| Bargelli, G; Buccoliero, AM; Fambrini, M; Marchionni, M; Mattei, A; Peruzzi, E; Pieralli, A; Scarselli, G; Taddei, GL | 1 |
| Bocciolone, L; Boveri, S; Casadio, C; Franchi, D; Minig, L; Sideri, M | 1 |
| Coomarasamy, A; Gallos, ID; Gupta, JK; Papapostolou, TK; Shehmar, M; Thangaratinam, S | 1 |
| Arnes, M; Hanssen, K; Larsen, K; Moe, B; Orbo, A; Pettersen, I | 1 |
| Kim, JW; Lee, TS; Nam, BH; Ryu, HS; Seong, SJ; Song, ES | 1 |
| Huang, XH; Wang, X | 1 |
| Haoula, ZJ; Powell, MC; Walker, KF | 1 |
| Knapp, P; Kołodziejczak, M; Kuźmicki, M | 1 |
| Gallos, ID; Gupta, JK | 1 |
| Gemzell-Danielsson, K; Heikinheimo, O | 1 |
| Holland, C; Wan, YL | 1 |
| Ionouchene, SV; Pashov, AI; Tskhay, VB | 1 |
| Feng, S; Hong, S; Li, L; Weng, M; Xie, M | 1 |
| Atkins, KA; Hanley, KZ; Mentrikoski, MJ; Shah, AA | 1 |
| D'Alessandro, P; Di Cello, A; Mocciaro, R; Morelli, M; Venturella, R; Zullo, F | 1 |
| Alfhaily, F; Ewies, AA | 1 |
| Elshmaa, NS; Fahmy, DM; Ismail, MT | 1 |
| Nwosu, EC; Sinha, A | 1 |
| Dhont, M; Wildemeersch, D | 1 |
| Bahamondes, L; de Andrade, KC; Leon-Martins, O; Petta, CA; Ribeiro-Huguet, P | 1 |
| Arnes, M; Maltau, JM; Straume, B; Vereide, AB; Ørbo, A | 1 |
| Kaino, T; Sager, G; Vereide, AB; Ørbo, A | 1 |
| Barlow, D; Guillebaud, J; Hampton, NR; Lowe, DG; Rauramo, I; Rees, MC | 1 |
| Bradley, LD | 1 |
| Clark, TJ; Gupta, JK; Neelakantan, D | 1 |
| Arnes, M; Kaino, T; Sager, G; Vereide, AB; Ørbo, A | 1 |
| Gupta, JK; Sinha, D; Varma, R | 1 |
| Sturdee, D | 1 |
| Boubli, B; Brun, JL; Dallay, D; Descat, E | 1 |
| De Wever, N; Dhont, M; Janssens, D; Pylyser, K; Tjalma, W; Verbeeck, G; Wildemeersch, D | 1 |
| Chaudhri, S; Ganesan, R; Hejmadi, RK; Rollason, TP | 1 |
| Gunther, C; Harrison, LI; Karara, AH; Lipp, R; Melikian, A; Zurth, C | 1 |
| Mansour, D | 1 |
| Chan, SS; Kwan, WH; Ng, DP; Tam, WH; Wong, AW; Yeo, W; Yu, MM; Yuen, PM | 1 |
| Higgins, M; Kelehan, P; O'Herlihy, C; Rizkalla, HF | 1 |
| Duan, Y; Li, Y; Qi, X; Zhao, W | 1 |
| Kresowik, J; Ryan, GL; Van Voorhis, BJ | 1 |
| Bhatia, K; Clark, TJ; Ganesan, R; Gupta, JK; Rollason, T; Soneja, H; Varma, R | 1 |
| Osborn, RA; Wren, BG | 1 |
| Ammälä, M; Nyman, T; Pekonen, F; Siegfried, S | 1 |
| Burnog, T; Hortíková, Z | 1 |
| Bargelli, G; Moncini, D; Scarselli, B; Scarselli, G; Taddei, GL | 1 |
| Abulafia, O; Sherer, DM | 1 |
| Bespoiasnaia, VV; Tumasian, KP; Voronovskaia, IV | 1 |
| Riphagen, FE | 1 |
42 review(s) available for levonorgestrel and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Uterine sparing management in patients with endometrial cancer: a narrative literature review.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Levonorgestrel; Pregnancy; Uterus | 2022 |
Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions.
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Levonorgestrel; Progestins | 2022 |
Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis.
Topics: Abortion, Spontaneous; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Precancerous Conditions; Pregnancy; Pregnancy Outcome | 2022 |
Endometrial Cancer Following Levonorgestrel-Releasing Intrauterine System Insertion in Young Women with Atypical Hyperplasia: Two Case Reports and Literature Review.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Progestins; Tumor Suppressor Protein p53 | 2022 |
Levonorgestrel-releasing intrauterine system versus systemic progestins in management of endometrial hyperplasia: A systemic review and meta-analysis.
Topics: Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Progestins | 2022 |
Unilateral hydroureteronephrosis after introduction of a levonorgestrel-releasing intrauterine system: a case report and literature review.
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2023 |
Role of hysteroscopy during conservative management of atypical endometrial hyperplasia and early-stage endometrial cancer in patients who desire pregnancy.
Topics: Conservative Treatment; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2022 |
Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Topics: Adult; Aged; Bias; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Nausea; Patient Dropouts; Patient Satisfaction; Progestins; Randomized Controlled Trials as Topic; Remission Induction; Time Factors; Uterine Hemorrhage; Weight Gain; Young Adult | 2020 |
Fertility-sparing management for endometrial cancer: review of the literature.
Topics: Administration, Oral; Drug Carriers; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Levonorgestrel; Metformin; Progestins | 2021 |
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Confidence Intervals; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen; Uterine Hemorrhage; Uterus | 2020 |
Levonorgestrel-Releasing Intrauterine System for Regression of Endometrial Hyperplasia.
Topics: Contraceptive Agents, Hormonal; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2021 |
Abnormal uterine bleeding in perimenopause.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Contraceptives, Oral, Combined; Diagnostic Imaging; Endometrial Hyperplasia; Endometrium; Female; Genital Neoplasms, Female; Humans; Hysteroscopy; Leiomyoma; Levonorgestrel; Middle Aged; Perimenopause; Pregnancy; Quality of Life; Uterine Hemorrhage | 2017 |
Menopausal hormone therapy: a better and safer future.
Topics: Administration, Cutaneous; Administration, Oral; Endometrial Hyperplasia; Estrogens; Female; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Progesterone; Progestins; Venous Thromboembolism | 2018 |
Oral and intrauterine progestogens for atypical endometrial hyperplasia.
Topics: Administration, Oral; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Randomized Controlled Trials as Topic | 2018 |
Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia.
Topics: Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2013 |
Indications and alternatives to hysterectomy.
Topics: Adenomyosis; Aromatase Inhibitors; Chronic Pain; Endometrial Hyperplasia; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Hysteroscopy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Pelvic Pain; Polyps; Uterine Artery Embolization; Uterine Diseases; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms | 2014 |
The role of levonorgestrel-releasing intrauterine system for endometrial protection in women with breast cancer taking tamoxifen.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices; Levonorgestrel; Tamoxifen | 2014 |
The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review.
Topics: Contraceptive Agents, Female; Endometrial Hyperplasia; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Patient Acceptance of Health Care; Perimenopause; Postmenopause; Quality of Life | 2015 |
Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials.
Topics: Administration, Oral; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Progestins; Randomized Controlled Trials as Topic; Treatment Outcome | 2015 |
[Levonorgestrel-releasing intrauterine system Mirena® (Bayer) for the prevention and treatment of endometrial adenocarcinoma and the incidence of other malignancies in women].
Topics: Adenocarcinoma; Carcinoma, Endometrioid; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Evidence-Based Medicine; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2015 |
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen | 2015 |
Levonorgestrel-Releasing Intrauterine Systems Versus Oral Cyclic Medroxyprogesterone Acetate in Endometrial Hyperplasia Therapy: A Meta-Analysis.
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Randomized Controlled Trials as Topic | 2017 |
Levonorgestrel-releasing intrauterine system: uses and controversies.
Topics: Contraception; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometriosis; Endometrium; Estrogen Replacement Therapy; Female; Genital Diseases, Female; HIV Infections; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Risk Assessment; Thrombophilia; Treatment Outcome; Uterine Neoplasms | 2008 |
The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review.
Topics: Adult; Australia; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Retrospective Studies | 2009 |
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen | 2009 |
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
Use of contraceptive methods among women with endometrial hyperplasia: a systematic review.
Topics: Adult; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2010 |
Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis.
Topics: Administration, Oral; Cohort Studies; Contraceptives, Oral, Synthetic; Controlled Clinical Trials as Topic; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Precancerous Conditions; Progestins; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2010 |
[Progress on surgical treatment and prevention of recurrence in endometrial polyps].
Topics: Age Factors; Dilatation and Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Hysterectomy; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Polyps; Progestins; Prognosis; Secondary Prevention; Severity of Illness Index | 2011 |
[Current possibilities of examination and preservative treatment in endometrial hyperplasia].
Topics: Antineoplastic Agents, Hormonal; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrium; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Women's Health | 2011 |
Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).
Topics: Contraceptive Agents, Female; Endometrial Hyperplasia; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Neoplasms | 2012 |
The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review.
Topics: Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Risk Factors; Treatment Outcome | 2011 |
Use of levonorgestrel-releasing intrauterine system in the prevention and treatment of endometrial hyperplasia.
Topics: Administration, Oral; Breast Neoplasms; Contraceptive Agents, Female; Drug Therapy, Combination; Endometrial Hyperplasia; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Progesterone; Tamoxifen | 2012 |
Endometrial polyp and the levonorgestrel intrauterine system--a case report and literature review.
Topics: Adenocarcinoma; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Polyps; Progesterone Congeners | 2002 |
Abnormal uterine bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Catheter Ablation; Contraceptives, Oral; Danazol; Dilatation and Curettage; Embolization, Therapeutic; Endometrial Hyperplasia; Endometrial Neoplasms; Endosonography; Estrogen Antagonists; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Hysteroscopy; Levonorgestrel; Magnetic Resonance Imaging; Perimenopause; Puberty; Risk Factors; Treatment Outcome; Uterine Hemorrhage; von Willebrand Diseases | 2005 |
Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.
Topics: Delayed-Action Preparations; Dysmenorrhea; Endometrial Hyperplasia; Endometrial Neoplasms; Endometriosis; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia | 2006 |
Levonorgestrel intrauterine system for endometrial protection.
Topics: Adult; Endometrial Hyperplasia; Female; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Middle Aged; Treatment Outcome; United Kingdom | 2006 |
[Endometrial hyperplasia: A review].
Topics: Biopsy; Endometrial Hyperplasia; Endometrium; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Hysteroscopy; Levonorgestrel; Menopause; Progestins; Uterine Hemorrhage; Uterus | 2006 |
Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system.
Topics: Contraceptive Agents, Female; Cost-Benefit Analysis; Endometrial Hyperplasia; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2007 |
Precancerous lesions of the endometrium and medical treatment.
Topics: Drug Monitoring; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Postmenopause; Precancerous Conditions; Premenopause; Progesterone Congeners; Progestins | 1997 |
Angiogenesis of the endometrium.
Topics: Carcinoma; Endometrial Hyperplasia; Endometrial Neoplasms; Endometriosis; Endometrium; Female; Humans; Leiomyoma; Levonorgestrel; Neovascularization, Physiologic | 1999 |
Intrauterine application of progestins in hormone replacement therapy: a review.
Topics: Animals; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipids; Patient Satisfaction; Progesterone; Progestins; Uterine Hemorrhage; Uterus | 2000 |
29 trial(s) available for levonorgestrel and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial pr
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Metformin; Obesity; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic | 2022 |
Vaginal micronized progesterone versus the levonorgestrel-releasing intrauterine system for treatment of non-atypical endometrial hyperplasia: A randomized controlled trial.
Topics: Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Progesterone; Prospective Studies; Quality of Life | 2023 |
Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study.
Topics: China; Endometrial Hyperplasia; Female; Fertility; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Pregnancy; Prospective Studies | 2023 |
Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Aldehyde Dehydrogenase 1 Family; Biomarkers; Biomarkers, Tumor; Body Mass Index; Carcinoma, Endometrioid; Contraceptive Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gene Expression; Humans; Intercellular Signaling Peptides and Proteins; Intrauterine Devices, Medicated; Ki-67 Antigen; Levonorgestrel; Membrane Proteins; Middle Aged; Neoplasm Grading; Neoplasm Staging; Quality of Life; Receptors, Cell Surface; Retinal Dehydrogenase; Treatment Outcome; Wnt Signaling Pathway; Young Adult | 2021 |
A Randomized Clinical Trial of Levonorgestrel Intrauterine System with or without Metformin for Treatment of Endometrial Hyperplasia without Atypia in Indian Women.
Topics: Adult; Contraceptive Agents, Hormonal; Drug Therapy, Combination; Endometrial Hyperplasia; Female; Humans; Hypoglycemic Agents; India; Intrauterine Devices, Medicated; Levonorgestrel; Metformin; Middle Aged; Treatment Outcome | 2021 |
Low-dose LNG-IUS as Therapy for Endometrial Hyperplasia. A Prospective Cohort Pilot Study.
Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pilot Projects; Precancerous Conditions; Prospective Studies | 2018 |
Prophylactic use of levonorgestrel-releasing intrauterine system in women with breast cancer treated with tamoxifen: a randomized controlled trial.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Delivery Systems; Endometrial Hyperplasia; Female; Humans; Levonorgestrel; Middle Aged; Tamoxifen | 2013 |
The efficacy of intrauterine versus oral progestin for the treatment of endometrial hyperplasia. A prospective randomized comparative study.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Patient Selection; Progestins; Prospective Studies; Treatment Failure | 2013 |
A comparison of the effect of levonorgestrel IUD with oral medroxyprogesterone acetate on abnormal uterine bleeding with simple endometrial hyperplasia and fertility preservation.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Fertility Preservation; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Metrorrhagia; Middle Aged; Ultrasonography; Young Adult | 2013 |
Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial.
Topics: Administration, Oral; Adult; Aged; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Middle Aged; Norway; Progestins; Risk; Single-Blind Method; Treatment Outcome | 2014 |
Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia.
Topics: Administration, Oral; Adult; Dydrogesterone; Egypt; Endometrial Hyperplasia; Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Patient Satisfaction; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Ultrasonography | 2015 |
[Hormone therapy alone for pre-cancerous conditions and early endometrial cancer: pros and cons].
Topics: Adult; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Goserelin; Humans; Levonorgestrel; Neoplasm Recurrence, Local; Precancerous Conditions; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Rate; Treatment Outcome | 2014 |
Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.
Topics: Abortion, Spontaneous; Adult; Biopsy; China; Embryo Implantation; Embryo Transfer; Endometrial Hyperplasia; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Prospective Studies; Time Factors; Treatment Outcome | 2015 |
Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Recurrence | 2016 |
Expression of PAX2 and PTEN Correlates to Therapy Response in Endometrial Hyperplasia.
Topics: Biomarkers, Tumor; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; PAX2 Transcription Factor; Progestins; PTEN Phosphohydrolase | 2015 |
HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia.
Topics: Biomarkers; Biopsy; Dose-Response Relationship, Drug; Drug Resistance; Endometrial Hyperplasia; Endometrium; Female; Gene Expression Regulation; Humans; Inclusion Bodies; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Precancerous Conditions; Proteins; Risk; Treatment Outcome; WAP Four-Disulfide Core Domain Protein 2 | 2016 |
Resectoscopic treatment of atypical endometrial polyps in fertile women.
Topics: Adult; Electrocoagulation; Endometrial Hyperplasia; Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Middle Aged; Polyps; Prognosis | 2008 |
Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: single arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2006).
Topics: Adult; Aged; Biopsy, Needle; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Patient Selection; Prospective Studies; Republic of Korea; Treatment Outcome; Ultrasonography | 2011 |
Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia.
Topics: Aged; Anticarcinogenic Agents; Biopsy; Drug Delivery Systems; Drug Monitoring; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Middle Aged; Progestins; Remission Induction | 2011 |
The combined GnRH-agonist and intrauterine levonorgestrel-releasing system treatment of complicated atypical hyperplasia and endometrial cancer: a pilot study.
Topics: Adenocarcinoma; Administration, Intravaginal; Adult; Antineoplastic Agents, Hormonal; Delayed-Action Preparations; Drug Delivery Systems; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Leuprolide; Levonorgestrel; Neoplasm Staging; Organ Sparing Treatments; Pilot Projects; Progestins; Young Adult | 2012 |
Efficacy of levonorgestrel-releasing intrauterine system versus oral progestins in treatment of simple endometrial hyperplasia without atypia.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progestins; Prospective Studies; Treatment Outcome; Ultrasonography | 2013 |
Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone.
Topics: Adult; Cell Nucleus; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged | 2003 |
Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
Topics: Administration, Oral; Adult; Aged; Apoptosis; bcl-2-Associated X Protein; Biopsy; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged; Precancerous Conditions; Progestins; Proto-Oncogene Proteins c-bcl-2 | 2005 |
Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women.
Topics: Administration, Oral; Adult; Animals; Contraceptive Agents, Female; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens; Female; Horses; Humans; Levonorgestrel; Middle Aged; Perimenopause; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2005 |
Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up.
Topics: Adult; Aged; Endometrial Hyperplasia; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progesterone Congeners; Treatment Outcome | 2007 |
Simultaneous estradiol and levonorgestrel transdermal delivery from a 7-day patch: in vitro and in vivo drug deliveries of three formulations.
Topics: Administration, Cutaneous; Animals; Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Endometrial Hyperplasia; Estradiol; Female; Gas Chromatography-Mass Spectrometry; Hormone Replacement Therapy; Humans; Levonorgestrel; Male; Mice; Middle Aged; Postmenopause; Radioimmunoassay; Skin Absorption; Therapeutic Equivalency | 2007 |
A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Polyps; Postmenopause; Premenopause; Tamoxifen; Uterine Diseases | 2007 |
[Klimonorm and precanceroses of the endometrium].
Topics: Climacteric; Cloprostenol; Drug Combinations; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Precancerous Conditions; Prospective Studies | 1994 |
[Combined hormone therapy in hyperplasia of the endometrium].
Topics: Adult; Drug Therapy, Combination; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progesterone Congeners; Recurrence; Uterus | 2000 |
64 other study(ies) available for levonorgestrel and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Levonorgestrel-releasing intrauterine system versus oral medroxyprogesterone acetate in infertile women with endometrial hyperplasia without atypia.
Topics: Abortion, Spontaneous; Adult; Cohort Studies; Endometrial Hyperplasia; Female; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Rate; Prospective Studies; Reproductive Techniques, Assisted; Treatment Outcome | 2021 |
Fertility sparing treatment in patients with endometrial cancer (FERT-ENC): a multicentric retrospective study from the Spanish Investigational Network Gynecologic Oncology Group (SPAIN-GOG).
Topics: Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Spain | 2022 |
Safety and efficacy of levonorgestrel-releasing intrauterine device in the treatment of atypical endometrial hyperplasia and early endometrial cancer.
Topics: Adult; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2022 |
Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia.
Topics: Aromatase Inhibitors; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Letrozole; Levonorgestrel; Male; Pregnancy; Progestins; Retrospective Studies | 2022 |
Clinical outcomes of levonorgestrel-releasing intrauterine device present during controlled ovarian stimulation in patients with early stage endometrioid adenocarcinoma and atypical endometrial hyperplasia after fertility-sparing treatments: 10-year exper
Topics: Adult; Carcinoma, Endometrioid; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Ovulation Induction; Pregnancy; Retrospective Studies; Tertiary Care Centers | 2023 |
Rare case of coexisting ovarian Brenner tumour and ovarian stromal hyperplasia presenting with persistent endometrial hyperplasia following treatment with levonorgestrel-intrauterine system.
Topics: Brenner Tumor; Endometrial Hyperplasia; Female; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms | 2022 |
Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
Topics: Endometrial Hyperplasia; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Progestins; Uterine Neoplasms; Venous Thromboembolism | 2023 |
Guideline No. 390-Classification and Management of Endometrial Hyperplasia.
Topics: Endometrial Hyperplasia; Female; Humans; Hysterectomy; Levonorgestrel; Progestins | 2019 |
Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy.
Topics: Adult; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Obesity, Morbid; Progestins; Retrospective Studies; Treatment Outcome | 2020 |
Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study.
Topics: Adolescent; Adult; Biopsy, Needle; Curettage; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Progestins; Prospective Studies; Republic of Korea; Young Adult | 2020 |
A survey of French gynecologists' knowledge and attitudes toward conservative treatment for fertility preservation in young patients with endometrial cancer.
Topics: Adenocarcinoma; Adult; Attitude of Health Personnel; Conservative Treatment; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; France; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Gynecology; Health Knowledge, Attitudes, Practice; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Male; Middle Aged; Patient Education as Topic; Pregnancy; Progestins; Reproductive Medicine; Surveys and Questionnaires | 2020 |
Expression of nuclear progesterone receptors (nPRs), membrane progesterone receptors (mPRs) and progesterone receptor membrane components (PGRMCs) in the human endometrium after 6 months levonorgestrel low dose intrauterine therapy.
Topics: Adult; Aged; Aged, 80 and over; Cell Line, Tumor; Cell Membrane; Cell Nucleus; Cell Proliferation; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrium; Female; Gene Expression; Humans; Levonorgestrel; Middle Aged; Pilot Projects; Receptors, Cell Surface; Receptors, Progesterone | 2020 |
Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Treatment Outcome; Young Adult | 2020 |
Advanced endometrial cancer following the insertion of the levonorgestrel-releasing intrauterine system in a 34-year-old woman: A case report.
Topics: Adult; Biopsy; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Grading; Neoplasm Staging; Treatment Outcome | 2020 |
Oncologic and obstetrical outcomes after fertility-preserving retreatment in patients with recurrent atypical endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Retreatment; Retrospective Studies; Young Adult | 2020 |
Predictive Accuracy of Progesterone Receptor B in Young Women with Atypical Endometrial Hyperplasia and Early Endometrial Cancer Treated with Hysteroscopic Resection plus LNG-IUD Insertion.
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Receptors, Progesterone; Retrospective Studies | 2021 |
Continued medical treatment for persistent early endometrial cancer in young women.
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy; Carcinoma, Endometrioid; Disease-Free Survival; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; Ultrasonography | 2021 |
Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Disease-Free Survival; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Middle Aged; Pregnancy; Prospective Studies; Treatment Outcome; Young Adult | 2021 |
Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol.
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Review Literature as Topic; Systematic Reviews as Topic | 2021 |
Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women.
Topics: Aged; Aged, 80 and over; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Intrauterine Devices; Levonorgestrel; Middle Aged; Neoplasm Grading; Postmenopause; Receptors, Progesterone; Retrospective Studies | 2017 |
Prediction of Relapse After Therapy Withdrawal in Women with Endometrial Hyperplasia: A Long-term Follow-up Study.
Topics: Administration, Oral; Adult; Aged; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Middle Aged; Progestins; Receptors, Progesterone; Recurrence | 2017 |
Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Letrozole; Levonorgestrel; Nitriles; Retrospective Studies; Triazoles; Young Adult | 2017 |
Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.
Topics: Adult; Biopsy, Needle; Cancer Care Facilities; Cohort Studies; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Precancerous Conditions; Retrospective Studies; Risk Assessment; Texas; Young Adult | 2018 |
The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia.
Topics: Conservative Treatment; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility; Humans; Hyperplasia; Levonorgestrel; Retrospective Studies | 2019 |
Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies | 2019 |
Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Contraceptives, Oral; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Hysterectomy; Levonorgestrel; Middle Aged; Odds Ratio; Progestins; Prospective Studies; Recurrence; Time Factors; Treatment Outcome | 2013 |
Predictive ability of estrogen receptor (ER), progesterone receptor (PR), COX-2, Mlh1, and Bcl-2 expressions for regression and relapse of endometrial hyperplasia treated with LNG-IUS: a prospective cohort study.
Topics: Adaptor Proteins, Signal Transducing; Adult; Cohort Studies; Cyclooxygenase 2; Endometrial Hyperplasia; Female; Humans; Immunohistochemistry; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; MutL Protein Homolog 1; Nuclear Proteins; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen; Receptors, Progesterone | 2013 |
Levonorgestrel-releasing intrauterine device in the treatment of abnormal uterine bleeding: a 6- and 12-month morphological and clinical follow-up.
Topics: Adult; Endometrial Hyperplasia; Endometrium; Female; Follow-Up Studies; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Middle Aged; Quality of Life; Ultrasonography | 2013 |
Nonsurgical treatment of endometrial hyperplasia: is the road less traveled the one we should be taking more?
Topics: Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Minimally Invasive Surgical Procedures; Obesity; Progestins | 2013 |
Prediction of regression and relapse of endometrial hyperplasia with conservative therapy.
Topics: Adult; Body Mass Index; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Forecasting; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progestins; Prognosis; Recurrence; Treatment Outcome | 2013 |
LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
Topics: Administration, Oral; Adult; Cohort Studies; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Intrauterine Devices; Levonorgestrel; Logistic Models; Middle Aged; Odds Ratio; Progestins | 2013 |
Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Outcome; Progesterone; Retrospective Studies; Treatment Outcome | 2014 |
Levonorgestrel-impregnated Intrauterine device reduces occurrence of hyperplastic polyps: a population-based follow-up cohort study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cohort Studies; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Polyps; Uterine Diseases | 2014 |
Evaluation of a levonorgestrel-releasing intrauterine system for treating endometrial hyperplasia in patients with polycystic ovary syndrome.
Topics: Endometrial Hyperplasia; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Polycystic Ovary Syndrome; Treatment Outcome | 2014 |
Management of Endometrial Hyperplasia: A Survey of Members of the Korean Gynecologic Oncology Group.
Topics: Combined Modality Therapy; Contraceptive Agents, Female; Disease Management; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Neoplasm Staging; Prognosis; Republic of Korea | 2015 |
Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).
Topics: Adult; Biopsy, Fine-Needle; Contraceptive Agents, Female; Curettage; Endometrial Hyperplasia; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Middle Aged; Prospective Studies; Republic of Korea | 2015 |
Endometrial Synovial-like Metaplasia Associated With Levonorgestrel-releasing Intrauterine System.
Topics: Adult; Biomarkers; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrium; Female; Foreign-Body Reaction; Humans; Immunohistochemistry; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Metaplasia; Middle Aged; Synovial Membrane | 2015 |
Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer.
Topics: Adult; Body Weight; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progestins; Young Adult | 2016 |
Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study.
Topics: Adult; Biopsy, Fine-Needle; Contraceptive Agents, Female; Disease Management; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Young Adult | 2016 |
Risk of relapse of endometrial hyperplasia is high and long-term treatment and follow up are recommended.
Topics: Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Levonorgestrel; Progestins; Recurrence | 2016 |
Levonorgestrel-Releasing Intrauterine System vs. Oral Progestins for Treatment of Endometrial Hyperplasia.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Education, Medical, Continuing; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progestins | 2016 |
Development of endometrioid adenocarcinoma despite Levonorgestrel-releasing intrauterine system: a case report with discussion and review of the RCOG/BSGE Guideline on the Management of Endometrial Hyperplasia.
Topics: Carcinoma, Endometrioid; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy, Vaginal; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Obesity, Morbid; Ovariectomy; Practice Guidelines as Topic; Risk Factors; Treatment Outcome | 2017 |
Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Observation; Risk Factors | 2008 |
[Management of menometrorrhagia in women with and without pregnancy intention: hierarchy of therapies].
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Hormonal; Embolization, Therapeutic; Endometrial Hyperplasia; Estrogens; Female; Humans; Hysterectomy; Infertility, Female; Leiomyoma; Levonorgestrel; Metrorrhagia; Polyps; Pregnancy; Progestins; Tranexamic Acid; Uterine Neoplasms; Uterus | 2008 |
Successful twin pregnancy achieved by assisted reproductive technology in a patient with polycystic ovary syndrome with complex atypical endometrial hyperplasia treated with levonorgestrel-releasing intrauterine system.
Topics: Adult; Endometrial Hyperplasia; Female; Humans; Infant, Newborn; Intrauterine Devices, Medicated; Levonorgestrel; Polycystic Ovary Syndrome; Pregnancy; Pregnancy, Multiple; Reproductive Techniques, Assisted | 2010 |
Prognostic significance of estrogen and progesterone receptor expression in LNG-IUS (Mirena) treatment of endometrial hyperplasia: an immunohistochemical study.
Topics: Adult; Aged; Biomarkers; Chi-Square Distribution; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Immunohistochemistry; Levonorgestrel; Middle Aged; Prognosis; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Statistics, Nonparametric | 2010 |
Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study.
Topics: Adult; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Hysterectomy; Intrauterine Devices; Levonorgestrel; Middle Aged; Recurrence; Treatment Outcome | 2011 |
Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.
Topics: Adult; Antineoplastic Agents, Hormonal; Drug Delivery Systems; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Infertility; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Ovarian Neoplasms; Pregnancy; Prospective Studies; Recurrence; Treatment Outcome; Young Adult | 2011 |
Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system.
Topics: Adult; bcl-2-Associated X Protein; Caspase 2; Contraceptives, Oral, Synthetic; Down-Regulation; Endometrial Hyperplasia; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Immunohistochemistry; Intrauterine Devices, Medicated; Levonorgestrel; Metallothionein; Middle Aged; Norway; Proto-Oncogene Proteins c-bcl-2; Receptors, Progesterone; Retrospective Studies; Statistics, Nonparametric | 2010 |
Comment on: What about the relapse of endometrial hyperplasia?
Topics: Anticarcinogenic Agents; Drug Delivery Systems; Endometrial Hyperplasia; Female; Humans; Levonorgestrel | 2013 |
[Effects of levonorgestrel-releasing intrauterine system on endometrial estrogen and progesterone receptors in patients with endometrial hyperplasia].
Topics: Adult; Endometrial Hyperplasia; Endometrium; Female; Gene Expression Regulation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Receptors, Estrogen; Receptors, Progesterone | 2012 |
Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Levonorgestrel; Megestrol Acetate; Menopause; Middle Aged; Prognosis; Treatment Failure; Young Adult | 2012 |
Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Topics: Administration, Intravaginal; Aged; Body Mass Index; Cell Proliferation; Drug Delivery Systems; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Follow-Up Studies; Humans; Italy; Levonorgestrel; Middle Aged; Obesity; Overweight; Postmenopause; Retrospective Studies; Risk; Secondary Prevention; Uterine Hemorrhage | 2013 |
Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system.
Topics: Adenoma; Aged; Antineoplastic Agents; Drug Delivery Systems; Endometrial Hyperplasia; Equipment Design; Female; Humans; Levonorgestrel; Middle Aged; Uterine Hemorrhage; Uterus | 2003 |
Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Delayed-Action Preparations; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Middle Aged; Progesterone Congeners; Treatment Outcome | 2003 |
The management of endometrial hyperplasia: an evaluation of current practice.
Topics: Aged; Aged, 80 and over; Biopsy; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Middle Aged; Remission Induction; Retrospective Studies; Treatment Outcome; Uterine Hemorrhage | 2006 |
Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.
Topics: Adult; Endometrial Hyperplasia; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Receptors, Progesterone; Stromal Cells | 2006 |
Morphologic changes in the endometrium associated with the use of the mirena coil: a retrospective study of 106 cases.
Topics: Contraceptive Agents, Female; Decidua; Endometrial Hyperplasia; Endometrium; Female; Humans; Levonorgestrel; Retrospective Studies; Stromal Cells | 2007 |
Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
Topics: Endometrial Hyperplasia; Endometriosis; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Retrospective Studies; Treatment Failure; Uterine Neoplasms; Uterus | 2008 |
Successful pregnancy following insertion of a levonorgestrel-releasing intrauterine system in two infertile patients with complex atypical endometrial hyperplasia.
Topics: Adult; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrium; Female; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Outcome | 2008 |
Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system.
Topics: Adenocarcinoma; Adult; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Treatment Failure | 2008 |
The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Contraceptive Agents, Female; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Middle Aged; Progestins; Treatment Outcome | 2008 |
The value of endometrial cell sampling in the management of post-menopausal women.
Topics: Cytodiagnosis; Dilatation and Curettage; Endometrial Hyperplasia; Endometrium; Estrogens; Female; Humans; Levonorgestrel; Menopause; Norgestrel; Polyps; Stereoisomerism; Uterine Neoplasms | 1981 |
Expression of mRNA for keratinocyte growth factor and its receptor in human endometrium.
Topics: Adult; Dilatation and Curettage; Endometrial Hyperplasia; Endometrium; Estrogens; Female; Fibroblast Growth Factor 10; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Gene Amplification; Growth Substances; Humans; Hysterectomy; Intrauterine Devices; Levonorgestrel; Menstrual Cycle; Polymerase Chain Reaction; Progesterone; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; RNA-Directed DNA Polymerase; RNA, Messenger | 1995 |